Additionally, Ro was the fifth-most seen brand during the 2025 World Series, with three separate spots — including its Serena Williams-led GLP-1 ad.
Year-to-date spending also continues to fall, down 7.6% year over year to $1.8 billion compared to $1.9 billion during the ...
Despite linear TV ad impressions declining 4.25% year over year in Q1 2025, ad spend on the channel grew 4% to $12.34 billion, per a report from iSpot shared with Marketing Dive. The total signals a ...
Paramount Global is teaming up with iSpot.tv to offer more transparency into consumers’ responses to ads — its latest partnership with a Nielsen competitor. iSpot’s new measurement offering, Outcomes ...
AbbVie’s Skyrizi took home the top spot for most pharma brand ad impressions in April, according to data released by iSpot.tv on Wednesday afternoon. The psoriasis treatment garnered an impressions ...
NEW YORK—The ad tech platform TripleLift has reached a deal with the TV measurement company iSpot.tv that will give all of TripleLift's programmatic clients access to iSpots’ Streaming Competitive ...
Jools Lebron sat down with Ad Age after her fireside chat to pull back the curtain on how she’s evolving her approach to brand partnerships.
As the Patrick Mahomes “GOAT NFL playoff QB” debate rages on, he has already clinched one title this season: The three-time Super Bowl MVP appeared in six campaigns during the past NFL season and ...
Though spending on pharmaceutical TV ads picked up last month following a summer slump, the third quarter’s overall total still paled in comparison to the preceding periods this year. In Q3, the top ...
In July, spending on TV ads for prescription drugs reached a low not seen since this time last year. Pharmas shelled out a combined $173.9 million to air ads for the top 10 drug brands last month, ...
Three upstart media-measurement companies — Comscore, iSpot and VideoAmp — are ready for primetime, and all other parts of the business of tracking TV audiences, according to a new audit by a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results